| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
caspase 3 | 0.351 | 0.923 | 0.10 |
|
phenotype | 0.200 | None | 1.000 | 3 | 0 | 2011 | 2016 | ||||||||
|
caspase 9 | 0.458 | 0.808 | 7.4E-06 |
|
phenotype | 0.200 | None | 1.000 | 3 | 0 | 2007 | 2016 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 2 | 0 | 2008 | 2011 | ||||||||
|
caspase 7 | 0.581 | 0.654 | 5.4E-05 |
|
phenotype | 0.200 | None | 1.000 | 2 | 0 | 2013 | 2016 | ||||||||
|
BCL2 associated agonist of cell death | 0.553 | 0.769 | 4.6E-03 |
|
phenotype | 0.200 | None | 1.000 | 2 | 0 | 2011 | 2013 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
phenotype | 0.200 | None | 1.000 | 2 | 0 | 2012 | 2013 | ||||||||
|
BCL2 associated X, apoptosis regulator | 0.417 | 0.885 | 0.32 |
|
phenotype | 0.200 | None | 1.000 | 2 | 0 | 2011 | 2013 | ||||||||
|
cyclin dependent kinase inhibitor 1B | 0.409 | 0.769 | 0.62 |
|
phenotype | 0.200 | None | 1.000 | 2 | 0 | 2005 | 2012 | ||||||||
|
cyclin E1 | 0.538 | 0.731 | 0.97 |
|
phenotype | 0.200 | None | 1.000 | 2 | 0 | 2003 | 2003 | ||||||||
|
mitogen-activated protein kinase 3 | 0.379 | 0.885 | 3.7E-02 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
mitogen-activated protein kinase 1 | 0.330 | 0.923 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1 | 0.488 | 0.769 | 0.74 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
Purkinje cell protein 4 | 0.682 | 0.423 | 2.2E-03 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
proliferating cell nuclear antigen | 0.382 | 0.846 | 0.98 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 1989 | 1989 | ||||||||
|
nuclear factor, erythroid 2 like 2 | 0.357 | 0.885 | 3.6E-03 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
nudix hydrolase 1 | 0.597 | 0.769 | 7.4E-12 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
matrix metallopeptidase 3 | 0.408 | 0.885 | 5.7E-15 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
plasminogen activator, urokinase | 0.425 | 0.923 | 2.3E-06 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
luteinizing hormone/choriogonadotropin receptor | 0.528 | 0.692 | 5.3E-08 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
leptin | 0.349 | 0.846 | 0.46 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
adiponectin, C1Q and collagen domain containing | 0.376 | 0.885 | 4.6E-09 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
BCL2 like 1 | 0.493 | 0.885 | 0.94 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
cyclin D3 | 0.554 | 0.654 | 0.98 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
stanniocalcin 2 | 0.573 | 0.692 | 0.27 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
caspase 8 | 0.404 | 0.923 | 3.7E-06 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2011 | 2011 |